Home > News > featured news > Rhythmlink Announces Investment Partnership With Graham Partners

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023 | Read time : 02:00 min

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses.

As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023.

“We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.”

This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship.

“Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.”

Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring.

About Rhythmlink

Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services.

About Graham Partners

Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Spotlight

Beyond the Bottom Line

Presented in the paper is a comprehensive overview
of the nuances of revenue cycle management (RCM)
and the intricacies of handling it internally in a
hard-pushed healthcare setting.

More featured news

Spotlight

Beyond the Bottom Line

Presented in the paper is a comprehensive overview
of the nuances of revenue cycle management (RCM)
and the intricacies of handling it internally in a
hard-pushed healthcare setting.

Related News

FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE

Komodo Health Introduces MapEnhance To Accelerate Multidimensional Insights for Healthcare and Life Sciences

Businesswire | April 27, 2023

Komodo Health today unveils MapEnhance, a network of specialty data partners that seamlessly connects into Komodo’s technology platform. MapEnhance extends the insight-generating capacity of Komodo’s Healthcare Map by combining it with exclusive and highly informative data curated from Komodo’s partners. Available only through the Komodo platform, MapEnhance provides Komodo’s customers with access to a multidimensional, real-world view of clinical events and patient populations at a level of resolution not previously available. MapEnhance enables customers to migrate away from legacy data aggregators and marketplaces and take advantage of a more cost-effective, technologically-enabled approach that drives rich, rapid insights. Users can more quickly perform comprehensive analytics, develop higher-performing predictive models, and conduct healthcare research on a unique combination of data products that support the unique needs of Life Sciences and healthcare teams spanning Clinical Development, Commercialization, Medical Affairs, and more. On top of Komodo's Healthcare Map – the industry’s most comprehensive, accurate source of de-identified patient-level data insights and analytics available – MapEnhance adds even more depth, dimension, and visibility into clinical encounters and patient populations. "Access to higher-fidelity patient journeys is required for real-world research at scale, and Komodo is leading the way for the industry by increasing connectivity between specialized datasets and the Healthcare Map,” said Arif Nathoo, MD, CEO and Co-Founder, Komodo Health. “As the FDA continues to advance standards for real-world evidence, Komodo is helping customers understand bias and reduce the inaccuracies perpetuated by legacy aggregators and marketplaces, which lack accountability for data quality and fidelity. MapEnhance introduces a superior alternative to what’s currently available on the market." MapEnhance curates insights from specialized proprietary partners, including Invitae, PointClickCare, Trio Health, and more. Users can rapidly identify a patient cohort in Komodo’s Healthcare Map and then see how much additional visibility MapEnhance partners can unlock on that cohort. Because MapEnhance is delivered on Komodo’s unified platform, data is cleansed, standardized, and seamlessly integrated, offering faster and timelier insights through a centralized process and technology infrastructure. MapEnhance combines insights generated from Komodo’s Healthcare Map with Precision Molecular Diagnostics: Features a range of proprietary cytogenetics, flow cytometry, FISH, and targeted or broad-panel genetics tests run on tissue, germ-line, and liquid biopsies (ctDNA) and focused on multiple therapeutic areas including cancer, cardiology, neurology, pediatric genetics, metabolic disorders, immunology, hematology, and more. High-Volume Standard Laboratory Diagnostics: Derived from the largest clinical laboratory providers in the U.S., including a broad menu of commonly ordered inpatient and outpatient lab tests, to drive earlier visibility into diagnosis and disease progression in both common and rare diseases. Electronic Medical Records: Unlocks unparalleled visibility into clinical encounters, with observations captured at the point of care, including characteristics of patients with highly complex conditions such as autoimmune diseases, diabetes, Alzheimer’s, and other acute and chronic conditions. Inpatient and Outpatient Facility Chargemasters: Provides deeper visibility into individual components of cost and utilization (including device-specific detail) associated with episodes of care across hospital settings, such as emergency departments, intensive-care units, and ambulatory surgery centers. “Our partnership with Komodo on MapEnhance presents an exciting opportunity to merge Trio’s unique real-world ecosystems, including direct access to healthcare providers, their clinical EMR data, and physician notes, with other powerful data sources,” said Brent Clough, CEO of Trio Health. “We are thrilled that MapEnhance will make it possible to append our data and insights with those from genetic testing, lab testing, claims, and hospitalizations. This is a huge step forward to bring together comprehensive clinical and cost-of-care insights to deliver real-world treatment recommendations that wouldn’t be possible without Komodo’s platform and expertise.” “PointClickCare’s clinical and comprehensive data shines an important light on insights into the long-term care of older adults — a population at higher risk for severe illness, and one that is often overlooked,” said Tara Goodman, Vice President, Life Sciences at PointClickCare. “Our partnership with Komodo and the introduction of MapEnhance are helping to break down silos in healthcare data across the industry and empower healthcare stakeholders with the most complete high-definition view of real-world patient journeys to fuel new research and enhance our collective understanding across complex disease areas.” Komodo Health is an industry leader in healthcare technology and data connectivity, powering secure, compliant use of de-identified patient data with analytics and insights that is unified within the Komodo platform. The continued enhancement of Komodo’s Healthcare Map, which powers the company’s technology platform and cloud-based application suite, is helping equip customers with reliable insights on disease trends to inform business decisions and ultimately help close gaps in care. About Komodo Health Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise software and machine learning that connects the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payers, providers, and developers, Komodo helps its customers unearth patient-centric insights at scale — marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision-making, close gaps in care, address disease burden, and help the enterprise create a more cost-effective, value-driven healthcare system.

AI, MEDICAL DEVICES

Notable launches Patient AI, the world's first use of large language models and GPT to bring personalization at scale to healthcare

prnewswire | April 17, 2023

Notable, the leading intelligent automation company for healthcare, launched Patient AI, the world's first use of large language models and GPT to bring personalization at scale to healthcare. Patient AI continuously reviews millions of data points across medical records and third-party data sets to develop a comprehensive clinical and social understanding of each patient. These insights are automatically translated into personalized recommendations that are surfaced to the patient before, after, and in between encounters through adaptive design without any staff involvement. The result is that patients are engaged at precisely the right moment to take action in achieving their health goals. As consumers, we have highly personalized experiences across retail, financial services, entertainment, and other aspects of our lives, and yet the healthcare experience has remained decidedly impersonal. This is despite the fact that trillions of dollars have been spent working to shift healthcare from what was a very analog industry to one that is far more digital. It is estimated that healthcare today accounts for a whopping 30% of the world's data volume. Yet, capitalizing on that data to personalize the patient experience and improve care has remained elusive for most health systems. The labor-intensive nature of mining, reading, and drawing conclusions from these data sets, combined with staffing shortages, has made it infeasible to personalize care for all patients. The result is fragmented, delayed, or deferred care, leading to poor outcomes for patients and inhibited revenue growth for health systems. "The entire industry is talking about generative AI and ChatGPT," said Pranay Kapadia, Chief Executive Officer and Co-Founder of Notable. "While others talk, we've been busy incorporating LLMs into our intelligent automation platform and the early results are incredibly encouraging. From the very beginning, we've embraced an iterative deployment methodology that allows us to capitalize on the rapid pace at which technology continues to evolve. Going forward, we are committed to safely deploying Patient AI into all of our digital assistant solutions to allow caregivers to practice at the top of their license." For example, a patient with lung cancer who frequently misses appointments due to a lack of transportation can be matched by Notable to A one-click ride booking with a rideshare service A recommendation to learn more about a clinical trial to treat symptoms of her cancer An opportunity to request a refill of an expiring medication The option to reschedule multiple upcoming appointments into a single day Alternatively, a patient being discharged after knee surgery can be matched with A home health nurse A medical equipment provider for crutches A series of periodic questionnaires to assess patient-reported outcomes (PROs) Notable presents all of these services to patients in an intuitively designed digital experience. Previously, this level of personalization required teams of professionals - including care coordinators, medical assistants, and nurses - and multiple hours of work to deeply examine a patient's clinical history, assess social determinants of health (SDOH), and manually contact the patient. Patient AI powers this level of proactive, personalized care without any increase in staff. Using GPT to scan existing clinical documentation, Patient AI can detect missed diagnoses and comorbidities to further improve a patient's care and risk accuracy. It is also able to identify lapsed insurance cards, incorrect addresses, eligible clinical trials, or costly care gaps in real-time across an entire patient population. "We are transforming how we engage patients through highly personalized care experiences," said Dave Henriksen, VP, Clinical Operations, Castell. "We have extended the capacity of our current workforce and equipped them with actionable insights to keep patients healthy. With Notable, we activate our patients at the right moment – without placing undue burden on our caregivers or adding more staff." "As an industry, it is imperative that we change the way we deliver care and that means embracing cutting-edge technology, like large language models," said Dr. Mark Cockley, Chief Clinical Officer, ThedaCare. "Intelligent automation is at the core of our digital transformation strategy. Notable is empowering us to deliver on our Triple Aim and our mission at ThedaCare: to improve the health and well-being of our communities by empowering each person to live their unique best life." See the Notable platform in action at HIMSS 2023 in booth #6827. To learn how to put your health system on the path to a personalized patient experience at scale About Notable Notable, the leading intelligent automation company for healthcare, is on a mission to optimize healthcare delivery for every patient and caregiver. Deployed at over 1,000 locations, Notable automates over half a million repetitive workflows every day across scheduling, registration, intake, referrals, and authorizations. The result: personalized, streamlined care for patients, the elimination of burdensome manual work for caregivers, and improved financial health for healthcare providers. Based in San Mateo, Calif., Notable is backed by leading investors, including ICONIQ Growth, Greylock Partners, F-Prime, Oak HC/FT, Maverick Ventures, and 8VC.

HEALTHCARE ANALYTICS

Personalized care company Validic acquires Trapollo

PRNewswire | May 16, 2023

Validic Inc., a market-leading digital health and personalized care company, has acquired the assets of Trapollo LLC, a connected health, technical support, and device logistics provider that helps healthcare organizations care for patients at home. Trapollo is a wholly-owned subsidiary of Cox Communications, Inc. With the acquisition of these Trapollo assets, Validic rounds out its core capabilities and becomes the company best positioned to make personalized healthcare a practical reality for patients and clinicians. Validic's EHR-integrated healthcare application ingests remotely collected health data from the world's largest health IoT platform to help healthcare organizations personalize chronic condition management, remote care, and support for healthy living. Adding in-house device logistics and technical support to a platform built for scale means that Validic offers the most proven way for healthcare providers to personalize care for their entire patient population. Even prior to the acquisition, Validic and Trapollo were jointly supporting the largest personalized care program in the country at a leading healthcare integrated delivery network on the West Coast, with more than 300,000 patients enrolled and thousands of devices shipped since inception. Now, for the first time, this winning solution is available for healthcare organizations nationwide. "We live in a time where consumers expect personalized experiences, and they aren't receiving them from their healthcare providers — 76% of patients are frustrated leaving their medical appointments and 69% would switch providers for better service. Imagine a system that helps clinicians efficiently deliver personalized care for every patient at scale," said Validic CEO Drew Schiller. "With the Trapollo assets, Validic, which has long been the leader in scaling remote and personalized healthcare programs, is now also a leading connected health and device logistics company, supporting the full range of personalized care programs - from BYO-tech, low-touch programs to high-risk, high-touch, fully kit-based remote monitoring and everything in between," said Schiller. Healthcare is not one size fits all. Patients have different goals and need different levels of care at different times. Validic offers healthcare organizations a single, cost-effective, EHR-embedded solution that Enables the creation of remote programs to support multiple clinical applications and patient support needs Integrates personal health data as a first-class citizen of the EHR — with program enrollment and visualizations in the patient chart, writing data to EHR flowsheets, and surfacing clinical alerts via the in-basket and in-basket pools Helps clinical teams operate more efficiently and effectively; 88% of clinicians say Validic saves them time Meets the full scope of patient device and support needs, from BYO-everything to pre-paired kits and phone support Eliminates the need to support multiple point solutions with a comprehensive enterprise platform Former Trapollo and current Validic Senior Vice President and General Manager Steve Nester echoed Schiller's enthusiasm and optimism stating: "We are joining Validic at a pivotal time in healthcare, as patients demand personalized and more convenient healthcare experiences that meet them where they are. We will bring our experience and expertise in device logistics, compassionate technical support, supply chain, and connected health from Trapollo to further Validic's mission of improving the quality of life by making personal data actionable." Validic is headquartered in Durham, N.C. Trapollo's former distribution center, which will now be operated by Validic, will remain in Sterling, VA. With the transaction, Cox becomes an investor in Validic. About Validic Founded in 2010, Validic Inc. is a digital health and personalized care company devoted to our mission of improving the quality of human life by making personal data actionable. With the world's largest health IoT platform and EHR-embedded remote care application, we help healthcare organizations give every person tailored interventions and personalized care, improving healthcare efficiency and delivery, and empowering people to play an active role in their health and well-being.